Multicenter prospective study on the usefulness and safety of edoxaban replacement before the endoscopic therapy with high-risk bleeding group during anticoagulant therapy with warfari
Not Applicable
- Conditions
- Disestive disorders requiring the endoscopic therapy in high-risk bleeding group
- Registration Number
- JPRN-UMIN000021973
- Lead Sponsor
- Digestive and Lifestyle Diseases, Kagoshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient who has taken warfarin after heart valve replacement 2) The patient with severe comorbidity 3) The patient cannot be obtained with informed consent 4) The patient prohibited the participant of this study by their research investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method